|
|
5-羰基-8-羥基喹啉 |
| CAS No.: |
5852-78-8 |
| 分子式： |
C10H7NO3 |
| 分子量： |
189.17048 |
| 備注： |
中文名稱5-羰基-8-羥基喹啉中文同義詞8-羥基喹啉-5-羧酸;5-羰基-8-羥基喹啉英文名稱5-Carboxy-8-hydroxyquinoline英文同義詞5-Carboxy-8-hydroxyquinoline;8-Hydroxyquinoline-5-carboxylicAcid;IOX1;8-hydroxy-5-Quinolinecarboxylicacid;IOX1,>=98%;JMJD2Inhibitor,5-carboxy-8HQ;8-Hydroxyquinoline-5-carboxylicacid95%;JMJD2Inhibitor,5-carboxy-8HQ-CAS5852-78-8-CalbiochemCAS號5852-78-8分子式C10H7NO3分子量189.17EINECS號相關(guān)類別小分子抑制劑，天然產(chǎn)物;染料中間體;小分子;Inhibitors;Aromatics,Heterocycles,Pharmaceuticals,Intermediates&FineChemicals;123456Mol文件5852-78-8.mol結(jié)構(gòu)式5-羰基-8-羥基喹啉性質(zhì)熔點(diǎn)301°C(decomp)沸點(diǎn)464.5±30.0°C(Predicted)密度1.480±0.06g/cm3(Predicted)儲存條件2-8°C溶解度DMSO：可溶10mg/mL，澄清酸度系數(shù)(pKa)1.82±0.10(Predicted)形態(tài)粉末顏色白色至棕色穩(wěn)定性自購買之日起1年內(nèi)保持穩(wěn)定。DMSO中的溶液可在-20°下保存長達(dá)3個月。InChIKeyJGRPKOGHYBAVMW-UHFFFAOYSA-N5-羰基-8-羥基喹啉用途與合成方法生物活性IOX1，是2OG氧合酶(2OGoxygenases)的有效廣譜抑制劑，包括JmjC去甲基酶。IOX1抑制KDM4C，KDM4E，KDM2A，KDM3A和KDM6B的IC50值分別為0.6μM，2.3μM，1.8μM，0.1μM和1.4μM。IOX1抑制ALKBH5。體外研究IOX1(0-200μM;2hours)inhibitstheproliferationandmigrationofvascularsmoothmusclecells(VSMCs)stimulatedwithangiotensinII(AngII)inaconcentration-dependentmanner.IOX1(200μM;24hours)blocksthecellcycleprogressionofangiotensinII(AngII)-VSMCsbyincreasingthepercentageofcellsintheG0/G1phase.IOX1(50-200μM;2hours)attenuatescyclinD1andupregulatesp21mRNAlevelsinaconcentration-dependent.IOX1(50-200μM;2hours)mediatescyclinD1andp21expressiChemicalbookonbyregainingH3K9me3.CellProliferationAssayCellLine:Vascularsmoothmusclecells(VSMCs)Concentration:50μM,100μM,200μMIncubationTime:Pretreated2hoursResult:Exhibitedadecreaseinproliferationandmigration.CellCycleAnalysisCellLine:Vascularsmoothmusclecells(VSMCs)Concentration:200μMIncubationTime:24hoursResult:SloweddowntheprogressionofthecellcyclefromtheG0/G1totheSphase.RT-PCRCellLine:Vascularsmoothmusclecells(VSMCs)Concentration:50μM,100μM,200μMIncubationTime:2hoursResult:DecreasedcyclinD1mRNAexpressionandincreasedp21mRNAexpression.RT-PCRCellLine:Vascularsmoothmusclecells(VSMCs)Concentration:50μM,100μM,200μMIncubationTime:2hoursResult:EnhancedthetotalproteinlevelsofH3K9me3.體內(nèi)研究IOX1(5-c-8HQ)(oralgavage;10-20mg/kg;12days)inhibitstumorgrowthandattenuatestheself-renewaloflivercancerstem-likecells(LCSCs)invivo.AnimalModel:Six-week-oldmaleBALB/cnudemiceDosage:10mg/kg,20mg/kgAdministration:12daysResult:Didnotresultinobviousadverseeffectsonmiceasdemonstratedbynobodyweightreductionandnotoxicitytothemajororgansaftertreatment.InhibitedLCSCorthotopicgrafttumorgrowth.SignificantlyreducedtheproteinlevelsofEpCAMandSox9inLCSCorthotopicgrafttumorsnhibitedLCSCorthotopicgrafttumorgrowth.DecreasedKi67-positivetumorcellsandmarkedlyreducedthetumorsphereformationabilitiesofLCSCsinadose-dependentmanner.安全信息 |
| 結(jié)構(gòu)式： |
 |
 |
|
|
聯(lián)系人： |
金經(jīng)理 |
地 址： |
湖北省武漢市東湖新技術(shù)開發(fā)區(qū)光谷大道03號 |
郵 編： |
430000 |
電 話： |
18995560451 |
手 機(jī)： |
15102708508 |
傳 真： |
18995560451 |
Q Q： |
 |
網(wǎng) 址： |
www.hbdhchem.com |
電子郵件： |
709783996@qq.com |
|
聲明：以上信息未經(jīng)本網(wǎng)證實(shí),僅供參考,華夏化工網(wǎng)不承擔(dān)任何風(fēng)險責(zé)任. |
|
